{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:20:42Z","timestamp":1793406042716,"version":"4.5.0"},"reference-count":129,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","aaojournal.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.ophtha.2017.05.012","type":"journal-article","created":{"date-parts":[[2017,9,21]],"date-time":"2017-09-21T06:16:23Z","timestamp":1505974583000},"page":"1678-1689","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":558,"title":["Update on the Management of Infectious Keratitis"],"prefix":"10.1016","volume":"124","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8898-9260","authenticated-orcid":false,"given":"Ariana","family":"Austin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Lietman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Rose-Nussbaumer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2017.05.012_bib1","first-page":"214","article-title":"Corneal blindness: a global perspective","volume":"79","author":"Whitcher","year":"2001","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.ophtha.2017.05.012_bib2","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1136\/bjophthalmol-2011-300539","article-title":"Global estimates of visual impairment: 2010","volume":"96","author":"Pascolini","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.05.012_bib4","doi-asserted-by":"crossref","first-page":"198","DOI":"10.4103\/0970-0218.120153","article-title":"Burden of corneal blindness in India","volume":"38","author":"Gupta","year":"2013","journal-title":"Indian J Community Med"},{"key":"10.1016\/j.ophtha.2017.05.012_bib5","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3109\/09286589609080122","article-title":"Incidence of corneal ulceration in Madurai district, South India","volume":"3","author":"Gonzales","year":"1996","journal-title":"Ophthalmic Epidemiol"},{"key":"10.1016\/j.ophtha.2017.05.012_bib6","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/0140-6736(91)91231-I","article-title":"Contact lenses and other risk factors in microbial keratitis","volume":"338","author":"Dart","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.ophtha.2017.05.012_bib7","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/ICO.0b013e318156caf2","article-title":"Risk factors and causative organisms in microbial keratitis","volume":"27","author":"Green","year":"2008","journal-title":"Cornea"},{"issue":"6 Pt 2","key":"10.1016\/j.ophtha.2017.05.012_bib8","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/ICL.0b013e318157c49d","article-title":"Epidemiology of contact lens-related inflammation and microbial keratitis: a 20-year perspective","volume":"33","author":"Keay","year":"2007","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.ophtha.2017.05.012_bib9","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1442-9071.1992.tb00718.x","article-title":"Epidemiological patterns of ocular trauma","volume":"20","author":"Thylefors","year":"1992","journal-title":"Aust N Z J Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.05.012_bib10","first-page":"557","article-title":"Prevalence and associated factors of corneal blindness in Ningxia in northwest China","volume":"7","author":"Sheng","year":"2014","journal-title":"Int J Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.05.012_bib11","doi-asserted-by":"crossref","first-page":"114","DOI":"10.4103\/0974-620X.57310","article-title":"Epidemiological profile of fungal keratitis in urban population of West Bengal, India","volume":"2","author":"Saha","year":"2009","journal-title":"Oman J Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.05.012_bib12","first-page":"1778","article-title":"Ocular trauma in a rural south Indian population: the Aravind Comprehensive Eye Survey","volume":"111","author":"Nirmalan","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2017.05.012_bib13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0161-6420(96)30738-0","article-title":"The role of smears, cultures, and antibiotic sensitivity testing in the management of suspected infectious keratitis","volume":"103","author":"McLeod","year":"1996","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2017.05.012_bib14","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.ajo.2008.06.009","article-title":"Prospective comparison of microbial culture and polymerase chain reaction in the diagnosis of corneal ulcer","volume":"146","author":"Kim","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.05.012_bib15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/IIO.0b013e31822d64dc","article-title":"Diagnostic and therapeutic considerations in fungal keratitis","volume":"51","author":"Chang","year":"2011","journal-title":"Int Ophthalmol Clin"},{"key":"10.1016\/j.ophtha.2017.05.012_bib16","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1159\/000313988","article-title":"Comparative study of Gram stain, potassium hydroxide smear, culture and nested PCR in the diagnosis of fungal keratitis","volume":"44","author":"Badiee","year":"2010","journal-title":"Ophthalmic Res"},{"key":"10.1016\/j.ophtha.2017.05.012_bib17","first-page":"1961","article-title":"Use of potassium hydroxide, Giemsa and calcofluor white staining techniques in the microscopic evaluation of corneal scrapings for diagnosis of fungal keratitis","volume":"38","author":"Zhang","year":"2010","journal-title":"J\u00a0Int Med Res"},{"key":"10.1016\/j.ophtha.2017.05.012_bib18","doi-asserted-by":"crossref","first-page":"273","DOI":"10.4103\/0301-4738.53051","article-title":"Review of epidemiological features, microbiological diagnosis and treatment outcome of microbial keratitis: experience of over a decade","volume":"57","author":"Gopinathan","year":"2009","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.05.012_bib19","series-title":"Bacterial Keratitis","year":"2013"},{"key":"10.1016\/j.ophtha.2017.05.012_bib20","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1136\/bjo.69.1.2","article-title":"Epidemiological and clinical features of primary herpes simplex virus ocular infection","volume":"69","author":"Darougar","year":"1985","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.05.012_bib21","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00284-005-0289-2","article-title":"Evaluation of herpes simplex detection in corneal scrapings by three molecular methods","volume":"52","author":"El-Aal","year":"2006","journal-title":"Curr Microbiol"},{"key":"10.1016\/j.ophtha.2017.05.012_bib22","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1159\/000357558","article-title":"Fungal keratitis\u2014improving diagnostics by confocal microscopy","volume":"4","author":"Nielsen","year":"2013","journal-title":"Case Rep Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.05.012_bib23","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1136\/bjo.87.4.409","article-title":"Confocal microscopy of Aspergillus fumigatus keratitis","volume":"87","author":"Avunduk","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.05.012_bib24","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/ICO.0b013e318181cff7","article-title":"Role of confocal microscopy in deep fungal keratitis","volume":"28","author":"Das","year":"2009","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2017.05.012_bib25","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1097\/ICO.0b013e318064582d","article-title":"Sensitivity and specificity of confocal scan in the diagnosis of infectious keratitis","volume":"26","author":"Kanavi","year":"2007","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2017.05.012_bib26","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ophtha.2010.05.018","article-title":"Role of confocal microscopy in the diagnosis of fungal and acanthamoeba keratitis","volume":"118","author":"Vaddavalli","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2017.05.012_bib27","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.ajo.2008.05.030","article-title":"Assessment of the use of anterior segment optical coherence tomography in microbial keratitis","volume":"146","author":"Konstantopoulos","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.05.012_bib28","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/ICO.0b013e3181dae1f3","article-title":"In\u00a0vivo confocal microscopy and anterior segment optical coherence tomography in a case of alternaria keratitis","volume":"30","author":"Martone","year":"2011","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2017.05.012_bib29","unstructured":"Austin A, Schallhorn J, Geske M, et\u00a0al. Empiric treatment of bacterial keratitis: an international survey of corneal specialists. Br J Ophthalmol Open. [Accepted for publication]."},{"key":"10.1016\/j.ophtha.2017.05.012_bib30","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1136\/bjophthalmol-2013-304660","article-title":"Topical antibiotics for the management of bacterial keratitis: an evidence-based review of high quality randomised controlled trials","volume":"98","author":"McDonald","year":"2014","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.05.012_bib31","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.ophtha.2006.12.011","article-title":"Clinical efficacy of moxifloxacin in the treatment of bacterial keratitis: a randomized clinical trial","volume":"114","author":"Constantinou","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2017.05.012_bib32","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1001\/archopht.1995.01100100045026","article-title":"Efficacy of ofloxacin vs. cefazolin and tobramycin in the therapy for bacterial keratitis. Report from the Bacterial Keratitis Study Research Group","volume":"113","author":"O'Brien","year":"1995","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.05.012_bib33","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1016\/S0161-6420(96)30416-8","article-title":"Comparison of ciprofloxacin ophthalmic solution 0.3% to fortified tobramycin-cefazolin in treating bacterial corneal ulcers. Ciprofloxacin Bacterial Keratitis Study Group","volume":"103","author":"Hyndiuk","year":"1996","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2017.05.012_bib34","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1016\/S0161-6420(97)30009-8","article-title":"Ofloxacin monotherapy for the primary treatment of microbial keratitis: a double-masked, randomized, controlled trial with conventional dual therapy","volume":"104","year":"1997","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2017.05.012_bib35","article-title":"CDC publishes report on antibiotic resistance threats in the United States for the first time","volume":"18","author":"Team","year":"2013","journal-title":"Eurosurveillance"},{"key":"10.1016\/j.ophtha.2017.05.012_bib36","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.ajo.2008.01.025","article-title":"Ocular TRUST: nationwide antimicrobial susceptibility patterns in ocular isolates","volume":"145","author":"Asbell","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.05.012_bib37","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.ajo.2011.03.010","article-title":"Monitoring antibiotic resistance in ocular microorganisms: results from the Antibiotic Resistance Monitoring in Ocular micRorganisms (ARMOR) 2009 surveillance study","volume":"152","author":"Haas","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.05.012_bib38","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1136\/bjo.84.3.300","article-title":"Intraocular penetration of vancomycin eye drops after application to the medial canthus with closed lids","volume":"84","author":"Alster","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.05.012_bib39","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1001\/jamaophthalmol.2013.1718","article-title":"Fluoroquinolone treatment and susceptibility of isolates from bacterial keratitis","volume":"131","author":"Ray","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.05.012_bib40","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1167\/iovs.12-11246","article-title":"Moxifloxacin susceptibility mediates the relationship between causative organism and clinical outcome in bacterial keratitis","volume":"54","author":"Oldenburg","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2017.05.012_bib41","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1093\/cid\/cis189","article-title":"Relationship of in\u00a0vitro susceptibility to moxifloxacin and in\u00a0vivo clinical outcome in bacterial keratitis","volume":"54","author":"Lalitha","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ophtha.2017.05.012_bib42","first-page":"1569","article-title":"Inhibition of purified collagenase from alkali-burned rabbit corneas","volume":"30","author":"Burns","year":"1989","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2017.05.012_bib43","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1600-051X.1995.tb00120.x","article-title":"Doxycycline inhibits neutrophil (PMN)-type matrix metalloproteinases in human adult periodontitis gingiva","volume":"22","author":"Golub","year":"1995","journal-title":"J\u00a0Clin Periodontol"},{"key":"10.1016\/j.ophtha.2017.05.012_bib44","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0002-9394(01)00913-8","article-title":"Treatment of recalcitrant recurrent corneal erosions with inhibitors of matrix metalloproteinase-9, doxycycline and corticosteroids","volume":"132","author":"Dursun","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.05.012_bib45","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1001\/archopht.1987.01060020122043","article-title":"Systemic tetracycline treatment of alkali-induced corneal ulceration in rabbits","volume":"105","author":"Seedor","year":"1987","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.05.012_bib46","first-page":"179","article-title":"Effect of systemic tetracycline on progression of Pseudomonas aeruginosa keratitis in the rabbit","volume":"22","author":"Levy","year":"1990","journal-title":"Ann Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.05.012_bib47","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1001\/archophthalmol.2009.221","article-title":"The steroid controversy in bacterial keratitis","volume":"127","author":"Acharya","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.05.012_bib48","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1001\/archophthalmol.2008.503","article-title":"The case against the use of steroids in the treatment of bacterial keratitis","volume":"127","author":"Cohen","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.05.012_bib49","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1001\/archophthalmol.2008.504","article-title":"Rationale for adjunctive topical corticosteroids in bacterial keratitis","volume":"127","author":"Hindman","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.05.012_bib50","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1600-0420.2004.00229.x","article-title":"Efficacy of early systemic betamethasone or cyclosporin A after corneal alkali injury via inflammatory cytokine reduction","volume":"82","author":"Den","year":"2004","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.ophtha.2017.05.012_bib51","first-page":"2665","article-title":"Combined treatment with antioxidants and immunosuppressants on cytokine release by human peripheral blood mononuclear cells\u2014chemically injured keratocyte reaction","volume":"17","author":"Yi","year":"2011","journal-title":"Mol Vis"},{"key":"10.1016\/j.ophtha.2017.05.012_bib52","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0014-4835(87)80003-9","article-title":"The influence of topical corticosteroid therapy upon polymorphonuclear leukocyte distribution, vascular integrity and ascorbate levels in endotoxin-induced inflammation of the rabbit eye","volume":"44","author":"Williams","year":"1987","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.ophtha.2017.05.012_bib53","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s004170050118","article-title":"Effect of 0.1% dexamethasone on epithelial healing in experimental corneal alkali wounds: morphological changes during the repair process","volume":"236","author":"Chung","year":"1998","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.05.012_bib54","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1034\/j.1600-0420.1999.770203.x","article-title":"Influence of topical treatment on epithelial wound healing and pain in the early postoperative period following photorefractive keratectomy","volume":"77","author":"Tomas-Barberan","year":"1999","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.ophtha.2017.05.012_bib55","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/00003226-199209000-00008","article-title":"Recurrence of microbial keratitis concomitant with antiinflammatory treatment in an animal model","volume":"11","author":"Gritz","year":"1992","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2017.05.012_bib56","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1001\/archopht.1990.01070090103049","article-title":"Topical anti-inflammatory agents in an animal model of microbial keratitis","volume":"108","author":"Gritz","year":"1990","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.05.012_bib57","first-page":"CD005430","article-title":"Topical corticosteroids as adjunctive therapy for bacterial keratitis","author":"Herretes","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ophtha.2017.05.012_bib58","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3129\/i10-054","article-title":"Comparison of antibiotic-only and antibiotic-steroid combination treatment in corneal ulcer patients: double-blinded randomized clinical trial","volume":"46","author":"Blair","year":"2011","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.05.012_bib59","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1136\/bjo.74.9.528","article-title":"Topical steroids in the treatment of central and paracentral corneal ulcers","volume":"74","author":"Carmichael","year":"1990","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.05.012_bib60","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1136\/bjo.2008.147298","article-title":"Corticosteroids for bacterial corneal ulcers","volume":"93","author":"Srinivasan","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.05.012_bib61","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1001\/archophthalmol.2011.315","article-title":"Corticosteroids for bacterial keratitis: the Steroids for Corneal Ulcers Trial (SCUT)","volume":"130","author":"Srinivasan","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.05.012_bib62","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1001\/jamaophthalmol.2014.292","article-title":"Early addition of topical corticosteroids in the treatment of bacterial keratitis","volume":"132","author":"Ray","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.05.012_bib63","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.ajo.2012.06.001","article-title":"Nocardia keratitis: clinical course and effect of corticosteroids","volume":"154","author":"Lalitha","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.05.012_bib64","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ajo.2013.09.025","article-title":"The steroids for corneal ulcers trial (SCUT): secondary 12-month clinical outcomes of a randomized controlled trial","volume":"157","author":"Srinivasan","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.05.012_bib65","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1001\/jamaophthalmol.2013.778","article-title":"Association between cytotoxic and invasive Pseudomonas aeruginosa and clinical outcomes in bacterial keratitis","volume":"131","author":"Borkar","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.05.012_bib66","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/00003226-200208000-00004","article-title":"The epidemiological features and laboratory results of fungal keratitis: a 10-year review at a referral eye care center in South India","volume":"21","author":"Gopinathan","year":"2002","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2017.05.012_bib67","first-page":"264","article-title":"Epidemiological features and laboratory results of bacterial and fungal keratitis: a five-year study at a rural tertiary-care hospital in western Maharashtra, India","volume":"53","author":"Deorukhkar","year":"2012","journal-title":"Singapore Med J"},{"key":"10.1016\/j.ophtha.2017.05.012_bib68","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1136\/bjo.81.11.965","article-title":"Epidemiology and aetiological diagnosis of corneal ulceration in Madurai, South India","volume":"81","author":"Srinivasan","year":"1997","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.05.012_bib69","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/0002-9394(86)90641-0","article-title":"Ulcerative keratitis associated with contact lens wear","volume":"101","author":"Alfonso","year":"1986","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.05.012_bib70","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1001\/archopht.124.7.ecr60006","article-title":"Outbreak of Fusarium keratitis in soft contact lens wearers in San Francisco","volume":"124","author":"Bernal","year":"2006","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.05.012_bib71","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1016\/j.ophtha.2010.03.048","article-title":"Trends in fungal keratitis in the United States, 2001 to 2007","volume":"117","author":"Gower","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2017.05.012_bib72","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00003226-200005000-00010","article-title":"Spectrum of fungal keratitis at Wills Eye Hospital, Philadelphia, Pennsylvania","volume":"19","author":"Tanure","year":"2000","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2017.05.012_bib73","doi-asserted-by":"crossref","first-page":"877","DOI":"10.3109\/02713688609029240","article-title":"Corneal penetration of topical amphotericin B and natamycin","volume":"5","author":"O'Day","year":"1986","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.ophtha.2017.05.012_bib74","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1136\/bjo.2007.136515","article-title":"Voriconazole in the treatment of fungal eye infections: a review of current literature","volume":"92","author":"Hariprasad","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.05.012_bib75","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJM200201243460403","article-title":"Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever","volume":"346","author":"Walsh","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ophtha.2017.05.012_bib76","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1001\/jamaophthalmol.2013.1497","article-title":"The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs. voriconazole","volume":"131","author":"Prajna","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.05.012_bib77","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1136\/bjophthalmol-2014-306485","article-title":"Re-appraisal of topical 1% voriconazole and 5% natamycin in the treatment of fungal keratitis in a randomised trial","volume":"99","author":"Sharma","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.05.012_bib78","first-page":"CD004241","article-title":"Medical interventions for fungal keratitis","author":"FlorCruz","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ophtha.2017.05.012_bib79","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1128\/AAC.00762-06","article-title":"Voriconazole concentration in human aqueous humor and plasma during topical or combined topical and systemic administration for fungal keratitis","volume":"51","author":"Thiel","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ophtha.2017.05.012_bib80","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1345\/aph.1D128","article-title":"Voriconazole in fungal keratitis caused by Scedosporium apiospermum","volume":"38","author":"Hernandez Prats","year":"2004","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ophtha.2017.05.012_bib81","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jcrs.2007.09.031","article-title":"Use of voriconazole in fungal keratitis","volume":"34","author":"Jones","year":"2008","journal-title":"J\u00a0Cataract Refract Surg"},{"key":"10.1016\/j.ophtha.2017.05.012_bib82","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1001\/jamaophthalmol.2016.4096","article-title":"Effect of oral voriconazole on fungal keratitis in the Mycotic Ulcer Treatment Trial II (MUTT II): a randomized clinical trial","volume":"134","author":"Prajna","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.05.012_bib83","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/APO.0000000000000107","article-title":"Efficacy profile of intracameral amphotericin B. The often forgotten step","volume":"4","author":"Sharma","year":"2015","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"10.1016\/j.ophtha.2017.05.012_bib84","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1097\/ICO.0b013e31806c791e","article-title":"Therapeutic effect of intracameral amphotericin B injection in the treatment of fungal keratitis","volume":"26","author":"Yoon","year":"2007","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2017.05.012_bib85","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/00003226-200110000-00009","article-title":"Intracameral amphotericin B: initial experience in severe keratomycosis","volume":"20","author":"Kaushik","year":"2001","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2017.05.012_bib86","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/00003226-200210000-00004","article-title":"Intracameral amphotericin B injection in the management of deep keratomycosis","volume":"21","author":"Kuriakose","year":"2002","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2017.05.012_bib87","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3109\/09273948.2015.1057597","article-title":"Evaluation of intracameral amphotericin B in the management of fungal keratitis: randomized controlled trial","volume":"24","author":"Sharma","year":"2016","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.ophtha.2017.05.012_bib88","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/bjophthalmol-2014-305412","article-title":"Intrastromal voriconazole for deep recalcitrant fungal keratitis: a case series","volume":"99","author":"Kalaiselvi","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.05.012_bib89","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ajo.2008.02.023","article-title":"Evaluation of intrastromal injection of voriconazole as a therapeutic adjunctive for the management of deep recalcitrant fungal keratitis","volume":"146","author":"Prakash","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.05.012_bib90","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1136\/bjo.2010.192815","article-title":"Evaluation of intrastromal voriconazole injection in recalcitrant deep fungal keratitis: case series","volume":"95","author":"Sharma","year":"2011","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.05.012_bib91","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.survophthal.2012.01.005","article-title":"Herpes simplex epithelial and stromal keratitis: an epidemiologic update","volume":"57","author":"Farooq","year":"2012","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.05.012_bib92","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1001\/archopht.1989.01070020221029","article-title":"Epidemiology of ocular herpes simplex. Incidence in Rochester, Minn, 1950 through 1982","volume":"107","author":"Liesegang","year":"1989","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.05.012_bib93","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ophtha.2016.10.001","article-title":"Persistent impairment of quality of life in patients with herpes simplex keratitis","volume":"124","author":"Reynaud","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2017.05.012_bib94","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1386-6532(02)00263-9","article-title":"Herpes simplex virus resistance to antiviral drugs","volume":"26","author":"Morfin","year":"2003","journal-title":"J\u00a0Clin Virol"},{"key":"10.1016\/j.ophtha.2017.05.012_bib95","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1111\/ceo.12785","article-title":"Herpes simplex virus keratitis: an update of the pathogenesis and current treatment with oral and topical antiviral agents","volume":"44","author":"Tsatsos","year":"2016","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.05.012_bib96","doi-asserted-by":"crossref","first-page":"665","DOI":"10.2147\/TCRM.S58242","article-title":"Ganciclovir ophthalmic gel 0.15% for the treatment of acute herpetic keratitis: background, effectiveness, tolerability, safety, and future applications","volume":"10","author":"Chou","year":"2014","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.ophtha.2017.05.012_bib97","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/00003226-199707000-00004","article-title":"Ganciclovir ophthalmic gel (Virgan; 0.15%) in the treatment of herpes simplex keratitis","volume":"16","author":"Colin","year":"1997","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2017.05.012_bib98","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1016\/S0161-6420(94)31087-6","article-title":"Herpetic Eye Disease Study. A controlled trial of topical corticosteroids for herpes simplex stromal keratitis","volume":"101","author":"Wilhelmus","year":"1994","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2017.05.012_bib99","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1016\/S0161-6420(13)31155-5","article-title":"Herpetic Eye Disease Study. A controlled trial of oral acyclovir for herpes simplex stromal keratitis","volume":"101","author":"Barron","year":"1994","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2017.05.012_bib100","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1136\/bjo.2008.138065","article-title":"Comparison of oral antiviral therapy with valacyclovir or acyclovir after penetrating keratoplasty for herpetic keratitis","volume":"92","author":"Goldblum","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.05.012_bib101","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1076\/ceyr.25.4.243.13488","article-title":"Ocular penetration of acyclovir and its peptide prodrugs valacyclovir and val-valacyclovir following systemic administration in rabbits: an evaluation using ocular microdialysis and LC-MS","volume":"25","author":"Dias","year":"2002","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.ophtha.2017.05.012_bib102","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.4065\/mcp.2011.0309","article-title":"Antiviral drugs for viruses other than human immunodeficiency virus","volume":"86","author":"Razonable","year":"2011","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ophtha.2017.05.012_bib103","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1056\/NEJM199807303390503","article-title":"Acyclovir for the prevention of recurrent herpes simplex virus eye disease. Herpetic Eye Disease Study Group","volume":"339","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ophtha.2017.05.012_bib104","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S0140-6736(02)09837-9","article-title":"Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study","volume":"360","author":"Thomas","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ophtha.2017.05.012_bib105","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1136\/bjophthalmol-2014-305000","article-title":"Trends in bacterial and fungal keratitis in South India, 2002\u20132012","volume":"99","author":"Lalitha","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.05.012_bib106","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/ICO.0000000000000644","article-title":"Corneal collagen cross-linking for infectious keratitis: a systematic review and meta-analysis","volume":"35","author":"Papaioannou","year":"2016","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2017.05.012_bib107","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/ICO.0b013e318169d698","article-title":"Ultraviolet A\/riboflavin corneal cross-linking for infectious keratitis associated with corneal melts","volume":"27","author":"Iseli","year":"2008","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2017.05.012_bib108","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3109\/08820538.2010.518503","article-title":"Corneal cross linking for keratoconus","volume":"25","author":"Keating","year":"2010","journal-title":"Semin Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.05.012_bib109","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/ICO.0b013e31826672e2","article-title":"Effects of corneal cross-linking on contrast sensitivity, visual acuity, and corneal topography in patients with keratoconus","volume":"32","author":"Lamy","year":"2013","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2017.05.012_bib110","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.jcrs.2007.12.039","article-title":"Collagen crosslinking with riboflavin and ultraviolet-A light in keratoconus: long-term results","volume":"34","author":"Raiskup-Wolf","year":"2008","journal-title":"J\u00a0Cataract Refract Surg"},{"key":"10.1016\/j.ophtha.2017.05.012_bib111","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1001\/archophthalmol.2009.205","article-title":"Intraoperative and postoperative effects of corneal collagen cross-linking on progressive keratoconus","volume":"127","author":"Vinciguerra","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.05.012_bib112","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1869-5760-3-47","article-title":"Corneal cross-linking and infectious keratitis: a systematic review with a meta-analysis of reported cases","volume":"3","author":"Alio","year":"2013","journal-title":"J\u00a0Ophthalmic Inflamm Infect"},{"key":"10.1016\/j.ophtha.2017.05.012_bib113","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1167\/iovs.07-1592","article-title":"Antimicrobial efficacy of riboflavin\/UVA combination (365 nm) in\u00a0vitro for bacterial and fungal isolates: a potential new treatment for infectious keratitis","volume":"49","author":"Martins","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2017.05.012_bib114","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1097\/ICO.0b013e31823f8f48","article-title":"Photo-activated riboflavin therapy of refractory corneal ulcers","volume":"31","author":"Panda","year":"2012","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2017.05.012_bib115","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1097\/ICO.0b013e3181d2de91","article-title":"Infectious keratitis treated with corneal crosslinking","volume":"29","author":"Makdoumi","year":"2010","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2017.05.012_bib116","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1136\/bjophthalmol-2014-304944","article-title":"Collagen crosslinking in the management of advanced non-resolving microbial keratitis","volume":"98","author":"Shetty","year":"2014","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.05.012_bib117","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00417-011-1754-1","article-title":"UVA-riboflavin photochemical therapy of bacterial keratitis: a pilot study","volume":"250","author":"Makdoumi","year":"2012","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.05.012_bib118","doi-asserted-by":"crossref","first-page":"3950","DOI":"10.1167\/iovs.09-4013","article-title":"In\u00a0vitro efficacy of antifungal treatment using riboflavin\/UV-A (365 nm) combination and amphotericin B","volume":"51","author":"Sauer","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2017.05.012_bib119","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/ICO.0000000000000375","article-title":"Ultraviolet A\/riboflavin collagen cross-linking for treatment of moderate bacterial corneal ulcers","volume":"34","author":"Bamdad","year":"2015","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2017.05.012_bib120","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.ophtha.2014.01.011","article-title":"Collagen cross-linking with photoactivated riboflavin (PACK-CXL) for the treatment of advanced infectious keratitis with corneal melting","volume":"121","author":"Said","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2017.05.012_bib121","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1016\/j.ophtha.2014.06.043","article-title":"Re: Said et\u00a0al.: Collagen cross-linking with photoactivated riboflavin (PACK-CXL) for the treatment of advanced infectious keratitis with corneal melting (Ophthalmology. 2014;121:1377-82)","volume":"121","author":"Mittal","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2017.05.012_bib122","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ajo.2015.03.024","article-title":"Corneal cross-linking as an adjuvant therapy in the management of recalcitrant deep stromal fungal keratitis: a randomized trial","volume":"160","author":"Uddaraju","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.05.012_bib123","first-page":"19","article-title":"Cefazolin-gentamicin versus vancomycin-ceftazidime eye drops for bacterial corneal ulcers; a randomized clinical trial","volume":"4","author":"Dehghani","year":"2009","journal-title":"J\u00a0Ophthalm Vis Res"},{"key":"10.1016\/j.ophtha.2017.05.012_bib124","doi-asserted-by":"crossref","first-page":"77","DOI":"10.5372\/1905-7415.0501.009","article-title":"The efficacy and safety of 0.5% levofloxacin versus fortified cefazolin and amikacin ophthalmic solution for the treatment of suspected and culture-proven cases of infectious bacterial keratitis: a comparative study","volume":"5","author":"Kasetsuwan","year":"2011","journal-title":"Asian Biomed"},{"issue":"Pt 6","key":"10.1016\/j.ophtha.2017.05.012_bib125","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/eye.1999.220","article-title":"Comparison of topical 0.3% ofloxacin with fortified tobramycin plus cefazolin in the treatment of bacterial keratitis","volume":"13","author":"Panda","year":"1999","journal-title":"Eye"},{"key":"10.1016\/j.ophtha.2017.05.012_bib126","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ajo.2005.08.081","article-title":"Comparison of topical gatifloxacin 0.3% and ciprofloxacin 0.3% for the treatment of bacterial keratitis","volume":"141","author":"Parmar","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.05.012_bib127","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/00003226-200103000-00013","article-title":"Bacteriologic and clinical efficacy of ofloxacin 0.3% versus ciprofloxacin 0.3% ophthalmic solutions in the treatment of patients with culture-positive bacterial keratitis","volume":"20","author":"Prajna","year":"2001","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2017.05.012_bib128","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1097\/ICO.0b013e3181ca2ba3","article-title":"Randomized clinical study for comparative evaluation of fourth-generation fluoroquinolones with the combination of fortified antibiotics in the treatment of bacterial corneal ulcers","volume":"29","author":"Shah","year":"2010","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2017.05.012_bib129","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.ophtha.2012.11.013","article-title":"Evaluation of moxifloxacin 0.5% in treatment of nonperforated bacterial corneal ulcers: a randomized controlled trial","volume":"120","author":"Sharma","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2017.05.012_bib130","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1001\/archophthalmol.2010.102","article-title":"Comparison of natamycin and voriconazole for the treatment of fungal keratitis","volume":"128","author":"Prajna","year":"2010","journal-title":"Arch Ophthalmol"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642016325295?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642016325295?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T16:02:07Z","timestamp":1570118527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642016325295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":129,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S0161642016325295"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2017.05.012","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Update on the Management of Infectious Keratitis","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2017.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}